ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 68 filers reported holding ADMA BIOLOGICS INC in Q2 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38,255,644 | +21.1% | 10,685,934 | +24.8% | 0.01% | +18.2% |
Q2 2023 | $31,583,215 | +105540.1% | 8,559,137 | -5.2% | 0.01% | 0.0% |
Q1 2023 | $29,897 | +2.0% | 9,032,313 | +19.6% | 0.01% | 0.0% |
Q4 2022 | $29,304 | -99.9% | 7,552,507 | -13.2% | 0.01% | +22.2% |
Q3 2022 | $21,150,000 | +49.1% | 8,703,733 | +21.5% | 0.01% | +80.0% |
Q2 2022 | $14,181,000 | +19.7% | 7,162,189 | -5.7% | 0.01% | +25.0% |
Q1 2022 | $11,848,000 | -20.8% | 7,594,940 | -28.4% | 0.00% | 0.0% |
Q4 2021 | $14,964,000 | +92.3% | 10,612,600 | +54.1% | 0.00% | +100.0% |
Q3 2021 | $7,780,000 | -17.6% | 6,884,640 | +16.6% | 0.00% | -33.3% |
Q2 2021 | $9,446,000 | -20.6% | 5,903,659 | -12.7% | 0.00% | -25.0% |
Q1 2021 | $11,895,000 | +2274.3% | 6,758,962 | +2530.6% | 0.00% | – |
Q4 2020 | $501,000 | -18.0% | 256,937 | +0.6% | 0.00% | – |
Q3 2020 | $611,000 | -44.4% | 255,530 | -31.8% | 0.00% | – |
Q2 2020 | $1,098,000 | -49.9% | 374,744 | -50.7% | 0.00% | -100.0% |
Q1 2020 | $2,191,000 | +96.5% | 760,576 | +172.9% | 0.00% | – |
Q4 2019 | $1,115,000 | +87.4% | 278,700 | +108.3% | 0.00% | – |
Q3 2019 | $595,000 | +122.0% | 133,787 | +93.6% | 0.00% | – |
Q2 2019 | $268,000 | – | 69,094 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Biomark Capital Management Co. LLC | 1,433,304 | $6,464,000 | 99.88% |
Broadfin Capital, LLC | 3,249,829 | $14,657,000 | 2.31% |
Stonepine Capital Management, LLC | 831,731 | $3,751,000 | 2.28% |
Aisling Capital LLC | 3,608,171 | $16,273,000 | 2.14% |
Consonance Capital Management LP | 4,249,234 | $19,164,000 | 1.24% |
MORGENS WATERFALL VINTIADIS & CO INC | 375,000 | $1,691,000 | 1.20% |
Perceptive Advisors | 6,521,102 | $29,410,000 | 0.77% |
PURA VIDA INVESTMENTS, LLC | 325,000 | $1,466,000 | 0.59% |
683 Capital Management, LLC | 885,000 | $3,991,000 | 0.27% |
ARDSLEY ADVISORY PARTNERS LP | 80,000 | $361,000 | 0.05% |